Narsoplimab

Narsoplimab Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:Narsoplimab
CAS:2108782-45-0
Purity:98.56% (SEC-HPLC) Package:1mg;347USD|10mg;1450USD|5mg;886USD
Company Name: Aladdin Scientific
Tel:
Email: tp@aladdinsci.com
Products Intro: Product Name:Narsoplimab (anti-MASP2)
CAS:2108782-45-0
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:$79.9/100μg;$399.9/1mg;$1039.9/5mg;$1659.9/10mg;Bulk package Remarks:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Products Intro: Product Name:Narsoplimab
CAS:2108782-45-0
Purity:95% Remarks:Reach out to us for more information about custom solutions.
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 021-61312847; 18021002903
Email: 3008007409@qq.com
Products Intro: Product Name:Narsoplimab (anti-MASP2)
CAS:2108782-45-0
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:5mg Remarks:K10877
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Narsoplimab
CAS:2108782-45-0
Purity:95% Package:100ug;500ug;1mg

Narsoplimab manufacturers

  • Narsoplimab
  • Narsoplimab pictures
  • $263.00
  • 2026-05-21
  • CAS:2108782-45-0
  • Purity: 98.56% (SEC-HPLC)
  • Supply Ability: 10g
Narsoplimab Basic information
Product Name:Narsoplimab
Synonyms:Narsoplimab;Research Grade Narsoplimab(DHA04501);Narsoplimab (anti-MASP2);OMS 721;Research Grade Narsoplimab
CAS:2108782-45-0
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Narsoplimab Structure
Narsoplimab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Narsoplimab Usage And Synthesis
UsesNarsoplimab (OMS 721) is a high-affinity fully human immunoglobulin gamma 4 (IgG4) monoclonal antibody that binds MASP-2 and blocks lectin pathway activation. Narsoplimab can be used in research of hematopoietic stem-cell transplantation and SARS-CoV-2[1].
in vivo

Narsoplimab (10 mg/kg; i.v.; WT and Masp2-/- (KO) mice) decreases percentage of lymphocytes (Lym%) and increases percentage of neutrophils (Neu%)[1].

Animal Model:WT and Masp2-/- (KO) mice (C57BL/6N, female, 12-15 weeks old)[1]
Dosage:10 mg/kg
Administration:Intravenous injection
Result:Decreased percentage of lymphocytes (Lym%) and an increased percentage of neutrophils (Neu%).
References[1] Gao T, et, al. Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation. Signal Transduct Target Ther. 2022 Sep 14;7(1):318. DOI:10.1038/s41392-022-01133-5
Narsoplimab Preparation Products And Raw materials
Tag:Narsoplimab(2108782-45-0) Related Product Information
Alacizumab Pegol VeltuzuMab Farletuzumab Rosopatamab Gantenerumab Abrilumab Blosozumab ibritumomab tiuxetan Panitumumab Zolbetuximab